Biosurgery

Global Market Trajectory & Analytics

MCP10738

EXECUTIVE ENGAGEMENTS

POOL

13417
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1612
Interactions with Platform & by Email

PARTICIPANTS

403
Unique # Participated

VALIDATIONS

82
Responses Validated*

COMPANIES

10
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

63

PAGES

103

EDITION

9

PRICE

USD 4950

CODE

MCP10738


COMPETITIVE METRICS

COMPANY

D S N T

% *

Adaptos

Amend Surgical

Aroa Biosurgery Limited

B. Braun Melsungen AG

Baxter International, Inc.

Biom Up SA

CoreBone

CryoLife, Inc.

ECM Biosurgery, Inc.

Exabone

*Login to Participate & View Data Stacks
View 10 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Biosurgery Market to Reach $16 Billion by 2026

Amid the COVID-19 crisis, the global market for Biosurgery estimated at US$11.8 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2026, growing at a CAGR of 5.1% over the analysis period. Surgical Sealing Agents, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hemostatic Agents segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.7 Billion in 2021, While China is Forecast to Reach $2.8 Billion by 2026

The Biosurgery market in the U.S. is estimated at US$3.7 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2026 trailing a CAGR of 4.8% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Anti-Adhesion Agents Segment to Reach US$785.3 Million by the year 2026

In the global Anti-Adhesion Agents segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$453.4 Million in the year 2020 will reach a projected size of US$661.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

B. Braun Melsungen AG; BARD, A Becton, Dickinson Company; Baxter International, Inc.; Cohera Medical, Inc.; CryoLife, Inc.; Hemostasis, LLC; Integra LifeSciences Holdings Corporation; Johnson & Johnson; MAQUET Holding B.V. & Co. KG; Medtronic PLC; Pfizer, Inc.; Sanofi U.S.; Stryker Corporation

SEGMENTS

» Product (Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management, Bone Graft Substitutes)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Biosurgery Market to Witness Steady Growth
Table: Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and 2022
Bone Graft Substitutes to Account for Largest Share
North American Region to Dominate Market Growth
Table: Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and 2022
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
New Approvals to Support Market Growth
Various Strategies from Leading Players to Bolster Market Growth
Rapid Growth in Ageing Population Drives Market Growth
Table: Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
Rise in Worldwide Surgical Procedures to Fuel Market Growth
Table: Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981-2015
Table: Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001-2015
Rising Incidence of Injuries due to Trauma Supports Market Growth
Myriad Health End-Users to Drive Market Growth
Table: Percentage Breakdown of Biosurgery Market Shares by Application: 2018
Table: Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011-2017
Innovations to Spur Market Growth
Table: Total Sales of DermaPure: 2016-2018
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Soft Tissue Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Soft Tissue Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Biosurgery by Product - Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Surgical Sealing Agents, Hemostatic Agents, Anti-Adhesion Agents, Soft Tissue Management and Bone Graft Substitutes for the Years 2012, 2020 & 2027
Total Companies Profiled: 10

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com